Real-world Short and Long-Term Effectiveness of Risankizumab in Refractory Crohn's Disease: RISANCROHN Study from the ENEIDA Registry
M. Barreiro-de Acosta,L. Nieto-Garcia, M. Poncela, M. Aguas, C. Martinez Cuevas,F. Arguelles-Arias,M. Calvo,C. J. Gargallo-Puyuelo,L. Zabalza,P. Varela Trastoy,M. M. Bosca-Watts,D. Ceballos, C. Martinez-Pascual,F. Rodriguez-Moranta, M. L. de Castro Parga, P. Suarez,B. Camps,V Royo,I Baston-Rey,R. de Francisco,S. Garcia-Lopez, M. D. Martin-Arranz,I Alonso-Abreu, J. P. Gisbert,M. Rivero,B. Sicilia, I Nicolas, M. Teller,A. Ponferrada, E. Ricart, M. Algara, P. Fradejas,P. Robledo, L. Madero,A. Elorza,M. Piqueras,Y. Zabana, S. Porto-Silva, E. Domenech,R. Ferreiro-Iglesias JOURNAL OF CROHNS & COLITIS（2025）
AI 理解论文
溯源树
样例
